Impact of seizures and their prophylaxis with antiepileptic drugs on rehabilitation course of patients with traumatic or hemorrhagic brain injury.

antiepileptic drugs epilepsy hemorrhagic stroke neurorehabilitation traumatic brain injury

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 02 10 2022
accepted: 18 10 2022
entrez: 28 11 2022
pubmed: 29 11 2022
medline: 29 11 2022
Statut: epublish

Résumé

To determine whether, in patients undergoing rehabilitation after traumatic or hemorrhagic brain injury, seizures and the use of antiepileptic drugs (AEDs) negatively impact on functional outcome, and, in turn, whether prophylactic AED therapy can prevent the development of seizures. Observational retrospective study. Highly specialized inpatient neurorehabilitation clinic. Patients with traumatic brain injury (TBI), or hemorrhagic stroke (HS) consecutively admitted to our neurorehabilitation unit between January 1, 2009, and December 31, 2018. Patients' demographic data, neurological status (Glasgow Coma Scale), and rehabilitation outcome (Functional Independence Measure scale), both assessed on admission and on discharge, associated neurosurgical procedures (craniectomy, or cranioplasty), AED use, early or late seizures occurrence, and death during hospitalization. Of 740 patients, 162 (21.9%) had seizures, and prophylactic AEDs were started in 192 (25.9%). Multivariate logistic regression identified severity of brain injury as a risk factor for acute symptomatic seizures (ASS) in HS (OR = 1.800, 95%CI = 1.133-1.859, Severity of brain injury and occurrence of seizures during neurorehabilitation are the main driver of poor outcome in both HS and TBI. The possible detrimental role on the epileptogenic and functional outcome played by seizures prophylaxis with AEDs, nonetheless useful to prevent ASS if administered over the first week after the brain injury, warrants further investigation.

Identifiants

pubmed: 36438966
doi: 10.3389/fneur.2022.1060008
pmc: PMC9691976
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1060008

Informations de copyright

Copyright © 2022 Pingue, Mele, Biscuola, Nardone, Bagnato and Franciotta.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Stroke. 2016 Jun;47(6):e98-e169
pubmed: 27145936
J Neurol. 2020 Oct;267(10):3105-3111
pubmed: 32444981
Neuropharmacology. 2020 May 1;167:107735
pubmed: 31377200
Epilepsy Curr. 2018 Jul-Aug;18(4):260-268
pubmed: 30254527
Neurobiol Dis. 2019 Mar;123:42-58
pubmed: 29782966
World Neurosurg. 2016 Jun;90:525-529
pubmed: 26721615
Neurocrit Care. 2017 Oct;27(2):220-228
pubmed: 28324261
J Head Trauma Rehabil. 2017 Mar/Apr;32(2):E13-E17
pubmed: 27323218
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
J Crit Care. 2013 Oct;28(5):883.e9-13
pubmed: 23566730
Stroke. 2009 Dec;40(12):3810-5
pubmed: 19797183
Neurology. 2015 Apr 21;84(16):1705-13
pubmed: 25901057
Curr Opin Neurobiol. 2006 Jun;16(3):258-64
pubmed: 16713245
Sci Rep. 2021 Feb 25;11(1):4708
pubmed: 33633297
Aust J Physiother. 2009;55(1):65
pubmed: 19226247
Neurocrit Care. 2022 Feb;36(1):248-258
pubmed: 34286461
Stroke. 2017 Mar;48(3):802-804
pubmed: 28104834
Brain. 2016 Oct;139(Pt 10):2694-2705
pubmed: 27497491
Eur Stroke J. 2017 Jun;2(2):103-115
pubmed: 31008306
Epileptic Disord. 2020 Jun 1;22(3):252-263
pubmed: 32597766
JAMA Neurol. 2019 Apr 1;76(4):440-446
pubmed: 30688969
Epilepsia. 2010 Apr;51(4):671-5
pubmed: 19732133
QJM. 2003 Jan;96(1):67-74
pubmed: 12509651
J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2159-66
pubmed: 27289186
Brain Dev. 2017 Jun;39(6):464-469
pubmed: 28202262
Lancet Neurol. 2020 Jun;19(6):544-556
pubmed: 32109411
Drugs Aging. 2021 Apr;38(4):285-299
pubmed: 33619704
Nat Rev Dis Primers. 2018 May 03;4:18024
pubmed: 29722352
Crit Care Med. 2018 Sep;46(9):1480-1485
pubmed: 29923930
Pharmacotherapy. 2014;34(4):396-409
pubmed: 24277723
Curr Neurol Neurosci Rep. 2019 May 27;19(7):37
pubmed: 31134438
Stroke. 2016 Oct;47(10):2666-72
pubmed: 27608820
J Neurol. 2020 Jun;267(6):1774-1779
pubmed: 32130500
Epilepsy Behav. 2021 May;118:107939
pubmed: 33839453
Neurosurgery. 2017 Jan 01;80(1):6-15
pubmed: 27654000

Auteurs

Valeria Pingue (V)

Neurorehabilitation and Spinal Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.

Chiara Mele (C)

Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Stefania Biscuola (S)

Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Antonio Nardone (A)

Neurorehabilitation and Spinal Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Neurorehabilitation Unit, Istituti Clinici Scientifici Maugeri IRCCS, Montescano, PV, Italy.

Sergio Bagnato (S)

Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, Cefalù, PA, Italy.

Diego Franciotta (D)

IRCCS Mondino Foundation, Pavia, Italy.

Classifications MeSH